Serum lysyl oxidase concentration increases in long-standing systemic sclerosis: Can lysyl oxidase change over time?

Jokar, Mohammad Hassan; Jafaripour, Simin; Abdollahi, Nafiseh; Nazemipour, Maryam; Moradzadeh, Maliheh; Mansournia, Mohammad Ali

Jokar, Mohammad Hassan; Jafaripour, Simin; Abdollahi, Nafiseh; Nazemipour, Maryam; Moradzadeh, Maliheh; Mansournia, Mohammad Ali.

Afiliação

Jokar MH; Golestan Rheumatology Research Center, Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran.
Jafaripour S; Department of Medical Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abdollahi N; Golestan Rheumatology Research Center, Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran.
Nazemipour M; Psychosocial Health Research Institute, Iran University of Medical Sciences, Tehran, Iran.
Moradzadeh M; Golestan Rheumatology Research Center, Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran.
Mansournia MA; Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Arch Rheumatol ; 37(2): 261-270, 2022 Jun.

Article em En | MEDLINE | ID: mdl-36017203

Palavras-chave

Biomarker; hyperlipidemia; long-standing disease; lysyl oxidase; systemic sclerosis.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Arch Rheumatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google